Opioid-induced respiratory depression: Reversal by non-opioid drugs

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Van Der Schier, Rutger ^a   Roozekrans, Margot ^a   Van Velzen, Monique ^a   Dahan, Albert ^a   Niesters, Marieke ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPAKINE; DOXAPRAM; OPIATE; POTASSIUM CHANNEL BLOCKING AGENT; RESPIRATORY STIMULANT AGENT; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANALGESIA; ANTINOCICEPTION; ARTICLE; BRAIN STEM; BREATHING RATE; CAROTID BODY; CONTROL SYSTEM; HUMAN; MORBIDITY; MORTALITY; OPIOID INDUCED RESPIRATORY DEPRESSION; RESPIRATION CENTER; RESPIRATION DEPRESSION; RESPIRATORY DRIVE; RESPIRATORY NERVE CELL;

EID: 84907060663     PISSN: 20517599     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-79     Document Type: Article

References (42)

1. Dahan A, Aarts L, Smith T: Incidence, reversal and prevention of opioid-induced respiratory depression. Anesthesiology 2010, 112:226-38.
2. 2sensitivity. PLoS One 2007, 4:e239.
3. thedition. Edited by Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega R. Philadelphia: Lippincott, Williams & Wilkins; 2013:501-22.
4. Lötsch J, Dudziak R, Freyenhagen R, Marschner J, Geisslinger G: Fatal respiratory depression after multiple intravenous morphine injections. Clin Pharmacokinet 2006, 45:1051-60.
5. Volow ND, Frieden TR, Hyde PS, Cha SS: Medication-assisted therapies - Tackling the opioid overdose epidemic. New Eng J Med 2014, 370:2063-6.
6. Okie S: A flood of opioids, a rising tide of deaths. N Eng J Med 2010, 363:1981-5.
7. Oderda GM, Said Q, Eveans R, Stoddard G, Lloyd J, Jackson R, Rublee D, Samore MH: Opioid-related adverse events in surgical hospitalizations: Impact on cost and length of stay. Ann Pharmacother 2007, 41:400-6.
8. Davies EC, Green CF, Taylor S, Willimason PR, Motram DR, Pirmohamed M: Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient episodes. PLoS One 2009, 4:e4439.
9. Oderda GM, Gan TJ, Johnson BH, Robinson SB: Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother 2013, 27:62-70.
10. Pattinson KTS: Opioids and the control of respiration. Br J Anaesth 2008, 100:747-58.
11. Olofsen E, Boom M, Nieuwenhuijs D, Sarton E, Aarts L, Dahan A: Modeling the non-steady-state respiratory effects of remifentanil in awake and propofol sedated healthy volunteers. Anesthesiology 2010, 212:1382-95.
12. Brown KA, Laferrière A, Lakheeram I, Moss IR: Recurrent hypoxemia in children is associated with increased analgesic sensitivity to opiates. Anesthesiology 2006, 105:665-9.
13. Moss I, Brown KA, Laferrière A: Recurrent hypoxia in rats during development increases subsequent respiratory sensitivity to fentanyl. Anesthesiology 2006, 105:715-8.
14. Niesters M, Mahajan RP, Aarts L, Dahan A: High-inspired oxygen concentration further impairs opioid-induced respiratory depression. Br J Anaesth 2013, 110:837-41.
15. Mercadante S, Porzio G, Ferrera P, Aielli F, Adile C, Ficorella C, Giarratano A, Casuccio A: Tapentadol in cancer pain management: A prospective open-label study. Curr Med Opin 2012, 28:1775-9.
16. Golder FJ, Hewitt MW, McLeod JF: Respiratory stimulant drugs in the post-operative setting. Resp Physiol Neurobiol 2013, 189:395-402.
17. Olofsen E, van Dorp E, Aarts L, Smith TW, Dahan A, Sarton E: Naloxone reversal of morphine- and morphine-6-glucuronideindiced respiratory depression in healthy volunteers: A mechanism-based pharmacokinetic-pharmacodynamicmodeling study. Anesthesiology 2010, 112:1417-27.
18. 2P) potassium channel function but does not affect minimum alveolar concentration. Anesth Analg 2006, 102:779-85.
19. Cotten JF: TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats. Anesth Analg 2013, 116:810-6.
20. Bamagbade OA: Advantages of doxapram for post-ananesthesia recovery and outcomes in bariatric surgery patients with obstructive sleep apnea. Eur J Anaesthesiol 2011, 28:387-8.
21. Roozekrans M, van der Schrier R, Hoskins P, McLeod J, Dahan A: Doxapram reduces alfentanil plasma concentrations associated with an increase in cardiac output [abstract]. Anesthesiology 2013, 119:A3165.
22. McCartney CE, McClafferty H, Huibant JM, Rowan EG, Shipston MJ, Rowe IC: A cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltage and Ca-activated K (BK) channel alpha-subunits. Proc Natl Acad Sci 2005, 102: 17870-6.
23. Ca-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers. Br J Anaesth 2014, [Epub ahead of print].
24. rdAnnual Meeting of the Society of Anesthesia and Sleep Medicine: 10-11 October, 2013; San Francisco, CA.
25. Roozekrans M, van der Schrier R, Okkerse P, Hay J, McLeod J, Dahan A: Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Anesthesiology 2014, [Epub ahead of print].
26. Manzke T, Niebert M, Koch UR, Caley A, Vogelgesang S, Hülsmann S, Ponimaskin E, Müller U, Smart TG, Harvey RJ, Richter DW: Serotonin receptor 1A-modulated phosphorylation of glycine receptor α3 controls breathing in mice. J Clin Invest 2010, 120:4118-28.
27. Montandon G, Qin W, Liu H, Ren J, Greer JJ, Horner RL: PreBötzinger complex neurokinin-1 receptor-expressing neurons mediate opioid-induced respiratory depression. J Neurosci 2011, 31:1291-301.
28. Mitchell GS: Back to the future: Carbon dioxide chemoreceptors in the mammalian brain. Nat Neurosci 2004, 7:1288-90.
29. Ren J, Poon BY, Tang Y, Funk GD, Greer JJ: Ampakines alleviate respiratory depression in rats. Am J Resp Crit Care Med 2006, 174:1384-91.
30. Ren J, Ding X, Funk GD, Greer JJ: Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats. Anesthesiology 2009, 110:1364-70.
31. Oertel BG, Felden L, Tran PV, Bradshaw MH, Angst MS, Schmidt H, Johnson G, Greer JJ, Geisslinger G, Varney MA, Lötsch J: Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther 2010, 87:204-11.
32. Ren J, Lenal F, Yang M, Ding X, Greer JJ: Coadministration of the ampakine CX717 with propofol reduces respiratory depression and fatal apneas. Anesthesiology 2013, 118:1437-5.
33. Manzke T, Guenther U, Ponimaskin EG, Haller M, Deutschmann M, Schwarzacher S, Richter DW: 5HTA4(a) receptors avert opioidinduced breathing depression without loss of analgesia. Science 2003, 301:226-9.
34. Oertel BG, Schneider A, Rohrbacher M, Schmidt H, Tegeder I, Geisslinger G, Lötsch J: the partial 5-hydroxytriptamine 1A receptor agonist buspirone does not antagonize morphineinduced respiratory depression in humans. Clin Pharmacol Ther 2007, 81:59-68.
35. Lötsch J, Skarke C, Schneider A, Hummel T, Geisslinger G: The 5-hydroxytriptamine 4 receptor agonist mosapride does antagonize morphine-induced respiratory depression. Clin Pharmacol Ther 2005, 78:278-87.
36. Dahan A, Roozekrans M, van der Schrier R, Smith T, Aarts L: Primum non nocere or How to resolve drug-induced respiratory depression. Anesthesiology 2013, 118:1261-3.
37. Niesters M, Overdyk F, Smith T, Aarts L, Dahan A: Opioid-induced respiratory depression in paediatrics: A review of case reports. Br J Anaesth 2013, 110:175-82.
38. Dahan A, Overdyk F, Smith T, Aarts L, Niesters M: Pharmacovigilance: a review of opioid-induced respiratory depression in chronic pain patients. Pain Physician 2013, 16:E85-94.
39. Overdyk F, Dahan A, Roozekrans M, van der Schrier R, Aarts L, Niesters M: Opioid-induced respiratory depression (OIRD) in the acute care setting; A Compendium of Case Reports. Pain Manag 2014, [Epub ahead of print].
40. 2[abstract]. Anesthesiology 2008, 109:A1682.
41. Shaoul R: The value of Integrated Pulmonary Index (IPI) monitoring during endoscopies in children [abstract]. Anesth Analg 2011, 113:S20.
42. Curry JP, Lynn LA: Threshold monitoring, alarm fatigue, and the patterns of unexpected hospital death. APSF Newsletter 2011, 26:32.